These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37172332)

  • 21. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental techniques for screening of antiosteoporotic activity in postmenopausal osteoporosis.
    Satpathy S; Patra A; Ahirwar B
    J Complement Integr Med; 2015 Dec; 12(4):251-66. PubMed ID: 26215536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does estrogen adequately protect postmenopausal women against osteoporosis: an iconoclastic perspective.
    Orwoll ES; Nelson HD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1872-4. PubMed ID: 10372678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis.
    Fischer V; Haffner-Luntzer M
    Semin Cell Dev Biol; 2022 Mar; 123():14-21. PubMed ID: 34024716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis.
    Grigorie D; Neacşu E; Marinescu M; Popa O
    Rom J Intern Med; 2003; 41(4):409-15. PubMed ID: 15526523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European and North American Experience with HRT for the prevention of osteoporosis.
    Eriksen EF; Kassem M; Langdahl B
    Bone; 1996 Nov; 19(5 Suppl):179S-183S. PubMed ID: 8922659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgens and bone: clinical implications for menopausal women.
    Shoupe D
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S329-33. PubMed ID: 10076175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raloxifene: a review of its use in postmenopausal osteoporosis.
    Clemett D; Spencer CM
    Drugs; 2000 Aug; 60(2):379-411. PubMed ID: 10983739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective estrogen modulators in menopause.
    Gambacciani M
    Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Present and future pharmacotherapy for osteoporosis.
    Doggrell SA
    Drugs Today (Barc); 2003 Aug; 39(8):633-57. PubMed ID: 14566385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
    Ohta H
    Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases.
    Delmas PD
    J Clin Densitom; 2008; 11(2):325-38. PubMed ID: 18375161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Astragalus polysaccharides on ovariectomy-induced osteoporosis in mice.
    Huo J; Sun X
    Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equol exerts a protective effect on postmenopausal osteoporosis by upregulating OPG/RANKL pathway.
    Ni X; Wu B; Li S; Zhu W; Xu Z; Zhang G; Cui H; Bai Q; Wang J
    Phytomedicine; 2023 Jan; 108():154509. PubMed ID: 36288653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis.
    Lufkin EG; Wong M; Deal C
    Rheum Dis Clin North Am; 2001 Feb; 27(1):163-85, vii. PubMed ID: 11285993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.